Free cash flow
ResMed Free cash flow increased by 67.2% to $520.48M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.7%, from $557.87M to $520.48M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows an upward trend with a 27.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Detailed definition
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Peer comparison
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flowHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $198.62M | -$93.00M | $189.47M | $68.99M | $50.84M | $15.61M | $101.29M | $253.75M | $202.99M | $256.25M | $249.48M | $380.84M | $415.23M | $307.70M | $287.98M | $557.87M | $508.18M | $414.36M | $311.21M | $520.48M |
| QoQ Change | — | -146.8% | +303.7% | -63.6% | -26.3% | -69.3% | +549.0% | +150.5% | -20.0% | +26.2% | -2.6% | +52.7% | +9.0% | -25.9% | -6.4% | +93.7% | -8.9% | -18.5% | -24.9% | +67.2% |
| YoY Change | — | — | — | — | -74.4% | +116.8% | -46.5% | +267.8% | +299.2% | >999% | +146.3% | +50.1% | +104.6% | +20.1% | +15.4% | +46.5% | +22.4% | +34.7% | +8.1% | -6.7% |
Free cash flow at Other Companies
Frequently Asked Questions
- What is ResMed's free cash flow?
- ResMed (RMD) reported free cash flow of $520.48M in Q1 2026.
- How has ResMed's free cash flow changed year-over-year?
- ResMed's free cash flow decreased by 6.7% year-over-year, from $557.87M to $520.48M.
- What is the long-term trend for ResMed's free cash flow?
- Over 4 years (2021 to 2025), ResMed's free cash flow has grown at a 27.2% compound annual growth rate (CAGR), from $634.01M to $1.66B.
- What does free cash flow mean?
- The cash remaining after a company pays for its operating expenses and capital investments.